Royalty Pharma raises 2025 portfolio receipts guidance to $3.05B-$3.15B as integrated company advances biotech funding model Royalty Pharma raises 2025 portfolio receipts guidance to $3.05B-$3.15B as integrated company advances biotech funding model Post ContentrprxRead More You might also be interested in reading Litecoin Comeback: LTC Breaks Free And Guns For $400. August 6, 2025 In Mainstream ← Previous post Next post →